Skip to main content
OpenTrials

Clinical trial condition

Urothelial Cancer

Explore clinical trials studying Urothelial Cancer. Study availability and eligibility vary by location and protocol.

54 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Cancer trial results

Completed

Gemzar, Cisp, Sunitinib Urothelial Ca

NCT00821327

Conditions
Urothelial Cancer
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Advanced Medical Specialties Miami, Florida, United States
  • Florida Cancer Institute - New Hope New Port Richey, Florida, United States
  • Cancer Centers of Florida, P.A. Ocoee, Florida, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer

NCT05645692

Conditions
Urothelial Cancer
Locations
  • Cleveland Clinic Cleveland, Ohio, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Macquarie University Hospital Macquarie Park, New South Wales, Australia
  • Lyell McEwin Hospital Adelaide, South Australia, Australia
View all 56 locations
View Trial Details
Active, Not Recruiting

Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer

NCT02516241

Conditions
Urothelial Cancer
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Stanford, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site New Haven, Connecticut, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations

NCT03390504

Conditions
Urothelial Cancer
Locations
  • Alaska Urological Institute dba Alaska Clinical Research Center Anchorage, Alaska, United States
  • University of Calif Davis Medical Center Sacramento, California, United States
  • St. Helena Hospital - Martin-O'Neil Cancer Center St. Helena, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 345 locations
View Trial Details
Active, Not Recruiting

Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

NCT05059522

Conditions
Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +17 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • The Regents of the University of California Los Angeles, California, United States
View all 71 locations
View Trial Details
Active, Not Recruiting

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

NCT04223856

Conditions
Urothelial Cancer
Locations
  • Ironwood Cancer & Research Centers - Chandler Chandler, Arizona, United States
  • Arizona Oncology Associates PD - HOPE Tucson, Arizona, United States
  • Providence St Joseph Medical Center Burbank, California, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 260 locations
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer

NCT03036098

Conditions
Urothelial Cancer
Locations
  • Local Institution - 0001 Anchorage, Alaska, United States
  • Local Institution - 0115 Fresno, California, United States
  • St Joseph Heritage Healthcare Santa Rosa, California, United States
  • Local Institution - 0051 Boca Raton, Florida, United States
View all 174 locations
View Trial Details

Related conditions